PharmaTher Holdings Ltd.
PHRM
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.08M | -1.59M | -2.31M | -3.22M | -3.51M |
| Total Depreciation and Amortization | 0.00 | 300.00 | 600.00 | 900.00 | 1.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.10K | 178.00K | 158.30K | 555.80K | 571.00K |
| Change in Net Operating Assets | -237.70K | -429.00K | -461.00K | -232.60K | 199.30K |
| Cash from Operations | -1.25M | -1.84M | -2.61M | -2.90M | -2.74M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -225.10K | -225.10K | -225.10K |
| Cash from Investing | 0.00 | 0.00 | -225.10K | -225.10K | -225.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.00K | 35.00K | 35.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.70K | 25.70K | 25.70K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.23M | -1.81M | -2.81M | -3.12M | -2.96M |